Saturday, November 25, 2017 7:58:22 PM
Recent TTOO News
- T2 Biosystems Unveils T2Lyme Launch Plans and Provides Additional Business Updates • GlobeNewswire Inc. • 03/20/2024 11:30:00 AM
- T2 Biosystems to Host Investor Call on March 20, 2024 to Unveil its T2Lyme Launch Plans and Provide Additional Business Updates • GlobeNewswire Inc. • 03/19/2024 01:00:00 PM
- T2 Biosystems Announces New Publication Highlighting the Clinical Benefits and Performance of the T2Resistance Panel • GlobeNewswire Inc. • 03/18/2024 01:00:00 PM
- T2 Biosystems Receives Extension to Comply with Nasdaq Listing Requirement • GlobeNewswire Inc. • 03/12/2024 01:00:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/04/2024 09:34:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 09:31:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 09:30:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 09:30:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 09:00:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 09:00:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 09:00:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 09:00:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 10:17:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 10:00:04 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 02/15/2024 09:49:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 09:47:41 PM
- T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2023 Financial Results • GlobeNewswire Inc. • 02/15/2024 09:06:00 PM
- T2 Biosystems Announces Agreement with CRG for the Conversion of $15 Million of CRG Term Loan into Equity • GlobeNewswire Inc. • 02/15/2024 09:04:00 PM
- T2 Biosystems Announces Commercial Expansion Through Distributors in Europe and Asia • GlobeNewswire Inc. • 02/15/2024 09:02:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 01:15:02 AM
- T2 Biosystems Receives FDA 510(k) Clearance for the Expanded T2Bacteria Panel • GlobeNewswire Inc. • 02/12/2024 02:00:00 PM
- T2 Biosystems to Report Fourth Quarter and Full Year 2023 Financial Results and Business Updates on February 15, 2024 • GlobeNewswire Inc. • 02/07/2024 09:05:00 PM
- T2 Biosystems Announces Participation in NIH-funded Antibacterial Resistance Leadership Group (ARLG) Pilot Study for Pneumonia Patients • GlobeNewswire Inc. • 01/18/2024 02:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 09:00:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 09:00:19 PM
FEATURED POET and MultiLane Collaborate to Develop High-Speed Pluggable Transceivers for AI Networks • Mar 27, 2024 10:52 AM
Endexx Corporation (EDXC) Leverages Global Market Trends and Legislative Reforms to Spearhead Growth in the Cannabis and Plant-Based Wellness Sectors • EDXC • Mar 27, 2024 3:01 PM
Applied UV, Inc. Announces Pricing of $2.76 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules • AUVI • Mar 27, 2024 2:51 PM
Maybacks Global Entertainment Opens 23 More Stations in Important Major Cities • AHRO • Mar 27, 2024 9:00 AM
NxGen Brands Inc. Forecast to Deliver 140% Growth in Q1 2024 • NXGB • Mar 27, 2024 7:30 AM
Kona Gold Beverages, Inc. Strategic Advancements: Covert LLC Introduces Federally Legal D9 Gummies and Revamps Innovative eCommerce Platform, Propelling Toward $12 Million Annual Revenue Goal • KGKG • Mar 26, 2024 8:30 AM